Intellia Therapeutics (NTLA) P/BV US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/BV | ? | 8.06 | 2.17 | 2.58 | 1.32 | 1.45 | 2.27 | ||
| Changes by years, y/y, % | +39% | -73% | +19% | -49% | +10% | -24.1% | |||
Intellia Therapeutics. P/BV
Intellia Therapeutics. P/BV, changes, %
Intellia Therapeutics (NTLA) P/BV US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| P/BV | ? | 1.36 | 0.94 | 1.36 | 2.54 | 1.45 | 2.27 | |
| Changes by years, y/y, % | -48% | -63% | -39% | +18% | +7% | |||
| Changes by quarters, q/q, % | -37% | -31% | +44% | +87% | -43% | |||